Emerging in the arena of obesity management, retatrutide presents a unique approach. Unlike many current medications, retatrutide functions as a dual agonist, at once targeting both glucagon-like peptide-1 (GLP-1) and glucose-responsive insulinotropic hormone (GIP) binding sites. This dual stimulation fosters several helpful effects, such as enhanc… Read More